Deying Yang

Title: Deying Yang: Innovator in COVID-19 Vaccine Development

Introduction

Deying Yang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biomedical technology, particularly in the development of vaccines against COVID-19. His innovative work has garnered attention for its potential impact on public health.

Latest Patents

Deying Yang holds a patent for a SARS-COV-2 antigen polypeptide, a recombinant adeno-associated virus expressing the polypeptide, and a vaccine containing the virus. This patent outlines a method for preparing the recombinant adeno-associated virus, which involves co-incubating specific plasmids and transfecting cells to produce a fusion antigen polypeptide. The resulting composition is designed to immunize humans against COVID-19 by inducing the production of serum neutralizing antibodies.

Career Highlights

Yang's career is marked by his role at Hengda Biomedical Technology Co., Ltd., where he has been instrumental in advancing vaccine technology. His work focuses on innovative solutions to combat viral infections, particularly in the context of the ongoing pandemic.

Collaborations

Deying Yang collaborates with notable colleagues, including Chao Zhang and Zhongqiu Liu. These partnerships enhance the research and development efforts within the company, fostering a collaborative environment for innovation.

Conclusion

Deying Yang's contributions to vaccine development highlight his commitment to addressing global health challenges. His innovative approach and collaborative efforts position him as a key figure in the fight against COVID-19.